Eva Engelhardt
Fortune : 108 118 $ au 31/05/2026
Fortune : 108 118 $ au 31/05/2026
Eva Anette Engelhardt currently works at Bio-Rad Laboratories, Inc., as President-Clinical Diagnostics Group & EVP from 2024.
Ms. Engelhardt also formerly worked at CEPHEID, as Senior VP-Strategy & Marketing.
Ms. Engelhardt received her undergraduate degree and graduate degree from Royal Institute of Technology.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 11/05/2026 | 346 ( 0 % ) | 108 118 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| BIO-RAD LABORATORIES, INC. | Corporate Officer/Principal | 10/06/2024 |
| Sociétés | Poste | Fin |
|---|---|---|
| CEPHEID | Sales & Marketing | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 3 |
|---|---|
Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes life science research products & clinical diagnostics | Health Technology |
CEPHEID
CEPHEID Medical SpecialtiesHealth Technology Develops, manufactures and markets molecular diagnostic systems | Health Technology |
Royal Institute of Technology
Royal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national